Tokyo, June 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057601) titled 'A Retrospective Cohort Study of T-DXd administration in HER2-Positive, Low-Expressing Advanced Breast Cancer Patients with History of Interstitial Lung Disease' on June 15.
Study Type:
Observational
Primary Sponsor:
Institute - CSPOR-BC
Condition:
Condition - advanced recurrent breast cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety and effectiveness of T-DXd in patients with ILD history.
Cohort 1:ILD history by T-DXd
Cohort 2 ILD history by anticancer drugs other than T-DXd
Basic objectives2 - Safety
Eligibility:
Age-lower limit ...